Meningococcal surrogates of protection—serum bactericidal antibody activity
R Borrow, P Balmer, E Miller - Vaccine, 2005 - Elsevier
Despite the availability of anti-microbial agents effective against Neisseria meningitidis,
meningococcal disease continues to be a major global health problem, particularly in the very …
meningococcal disease continues to be a major global health problem, particularly in the very …
Vaccines and routine immunization strategies during the COVID-19 pandemic
EC Dinleyici, R Borrow, MAP Safadi… - Human vaccines & …, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now
responsible for one of the most challenging and concerning pandemics. By August 2020, there …
responsible for one of the most challenging and concerning pandemics. By August 2020, there …
Simultaneous Detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in Suspected Cases of Meningitis and Septicemia Using …
CE Corless, M Guiver, R Borrow… - Journal of clinical …, 2001 - Am Soc Microbiol
A single-tube 5′ nuclease multiplex PCR assay was developed on the ABI 7700 Sequence
Detection System (TaqMan) for the detection of Neisseria meningitidis, Haemophilus …
Detection System (TaqMan) for the detection of Neisseria meningitidis, Haemophilus …
Contamination and sensitivity issues with a real-time universal 16S rRNA PCR
CE Corless, M Guiver, R Borrow… - Journal of clinical …, 2000 - Am Soc Microbiol
A set of universal oligonucleotide primers specific for the conserved regions of the eubacterial
16S rRNA gene was designed for use with the real-time PCR Applied Biosystems 7700 (…
16S rRNA gene was designed for use with the real-time PCR Applied Biosystems 7700 (…
[HTML][HTML] Advances in the Development of Vaccines against Neisseria meningitidis
LKK Tan, GM Carlone, R Borrow - New England Journal of …, 2010 - Mass Medical Soc
Neisseria meningitidis remains a leading cause of meningitis and sepsis. This review
provides an update on our understanding of immunity against meningococcal infection. …
provides an update on our understanding of immunity against meningococcal infection. …
[HTML][HTML] Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 …
…, Z Amin-Chowdhury, DE Bennett, R Borrow… - The Lancet Digital …, 2021 - thelancet.com
Background Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis,
which are typically transmitted via respiratory droplets, are leading causes of invasive …
which are typically transmitted via respiratory droplets, are leading causes of invasive …
[HTML][HTML] Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
…, S Taylor, J Hewson, B Hallis, L Stapley, R Borrow… - Nature …, 2021 - nature.com
The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern
that waning immunity may predispose to reinfection. We analyzed the magnitude and …
that waning immunity may predispose to reinfection. We analyzed the magnitude and …
[HTML][HTML] Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational …
…, A Djennad, CL Sheppard, R Borrow… - The Lancet Infectious …, 2018 - thelancet.com
Background Pneumococcal conjugate vaccines (PCVs) have substantially reduced the
incidence of invasive pneumococcal disease caused by vaccine serotypes; however, …
incidence of invasive pneumococcal disease caused by vaccine serotypes; however, …
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
…, JJ Donnelly, D Medini, R Borrow - The Lancet infectious …, 2013 - thelancet.com
Background A novel multicomponent vaccine against meningococcal capsular group B (MenB)
disease contains four major components: factor-H-binding protein, neisserial heparin …
disease contains four major components: factor-H-binding protein, neisserial heparin …
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection
R Borrow, N Andrews, D Goldblatt… - Infection and …, 2001 - Am Soc Microbiol
The antibody data supporting the use of meningococcal serogroup C conjugate (MCC)
vaccines in the United Kingdom were generated by serum bactericidal assay (SBA) using rabbit …
vaccines in the United Kingdom were generated by serum bactericidal assay (SBA) using rabbit …